299 related articles for article (PubMed ID: 26397940)
21. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma.
Wang J; Qiu M; Xu Y; Li M; Dong G; Mao Q; Yin R; Xu L
Tumour Biol; 2015 Jul; 36(7):5523-8. PubMed ID: 25677908
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
[TBL] [Abstract][Full Text] [Related]
23. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
26. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
[TBL] [Abstract][Full Text] [Related]
27. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
[TBL] [Abstract][Full Text] [Related]
28. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
29. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
32. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
33. p14ARF repression induced by promoter methylation associated with metastasis in esophageal squamous cell carcinoma.
Ling Y; Zhang C; Shen R; Xu Y; Zhu C; Lu M; Liu Y; Zhang C
Dis Esophagus; 2014; 27(2):182-7. PubMed ID: 22973996
[TBL] [Abstract][Full Text] [Related]
34. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
35. CADM1 mRNA expression and clinicopathological significance in esophageal squamous cell carcinoma tissue.
Qian JB; Liu HB; Zhu Y; Lu F; Yang QC; Shen Y
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510248
[TBL] [Abstract][Full Text] [Related]
36. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma.
Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS
Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885
[TBL] [Abstract][Full Text] [Related]
37. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
38. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
39. Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
Oya H; Kanda M; Koike M; Iwata N; Niwa Y; Shimizu D; Takami H; Sueoka S; Hashimoto R; Ezaka K; Nomoto S; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Dis Esophagus; 2016 Aug; 29(6):663-9. PubMed ID: 25951896
[TBL] [Abstract][Full Text] [Related]
40. Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinoma.
Harada K; Baba Y; Ishimoto T; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Anticancer Res; 2015 Sep; 35(9):4617-24. PubMed ID: 26254350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
